We are seeking volunteer, multi-disciplinary, multi-specialty health professionals and consumer representatives to help with a new guideline on stroke prevention.
This guideline is being produced in association with the International Union of Angiology (IUA). It is focusing on disease of the main brain artery (the carotid artery) with implications for all arterial disease prevention. The aim is to help update the field and overcome procedural biases in existing guidelines.
This project is being performed in steps, and each step expected to last up to 6-12 months.
This project involves systematic reviews of guidelines and studies regarding how to best define and modify arterial disease risk factors (including hypertension, lipids, smoking etc) for primary and secondary prevention.
Consumers, in particular, can assist with one or more steps by helping make the guideline understandable, relevant and accessible.
All work is being performed via email. There is no need for meeting participation. All career stages welcome and variable time contributions can be accommodated.
Opportunities to participate are limited. If interested, please email a summary of why and how you would like to help to A/Prof Anne Abbott: Anne.L.Abbott@gmail.com
CASCOM is a prospective cohort study of patients with advanced carotid arterial disease (narrowing or stenosis) receiving current best medical intervention alone (lifestyle coaching and medication) for stroke prevention.
CASCOM is also a multi-national, multi-specialty, collaborative, quality assurance and evaluation project being conducted under the auspices of the International Union of Angiology.
CASCOM will include patients with or without prior stroke or transient ischaemic attack who do not undergo a carotid procedure for any reason, including lack of proven procedural benefit and where procedural use is considered unethical.
We will expect stroke rates in CASCOM will be at least 50% lower than those seen in past randomised trials of medical intervention and carotid endarterectomy (surgery). We expect CASCOM will provide new evidence that past randomised trials are outdated and set new improved standards for prevention of stroke and other arterial disease complications.